$1.63
0.031.87%
Last update: Nov 2, 4:37 PM
InMed Pharmaceuticals Inc (INM) Stock Price, Quote, News & History
INMNASDAQ
Mentari Therapeutics secures $200 million in private financing before merging with InMed Pharmaceuticals to fund migraine therapies.
You can purchase shares of InMed Pharmaceuticals (NASDAQ:INM) through any online brokerage.
Other companies in InMed Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
There is no analysis for InMed Pharmaceuticals to provide a consensus price target.
The stock price for InMed Pharmaceuticals (NASDAQ: INM) is $1.63 last updated November 2, 2026 at 4:37 PM EST.
There are no upcoming dividends for InMed Pharmaceuticals.
InMed Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for InMed Pharmaceuticals.
InMed Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of...
